Biogen (BIIB) Inventory Average (2009 - 2026)

Biogen (BIIB) has reported Inventory Average for 18 consecutive years, with $2.1 billion the latest figure, recorded in Q1 2026.

• In Q1 2026, Inventory Average fell 13.04% year-over-year to $2.1 billion; the TTM figure through Mar 2026 stood at $2.1 billion (down 13.04% YoY), while the FY2025 annual figure was $2.3 billion, down 7.2% from the prior year.
• Inventory Average came in at $2.1 billion for Q1 2026 at Biogen, down from $2.2 billion in the prior quarter.
• The five-year high for Inventory Average was $2.8 billion in Q4 2023, with the low at $1.3 billion in Q2 2022.
• Average Inventory Average over 5 years is $2.0 billion, with a median of $2.2 billion recorded in 2025.
• Across the five-year window, Inventory Average jumped 102.61% in 2023 and slipped 13.04% in 2026, its largest moves.
• Year by year, Inventory Average stood at $1.4 billion in 2022, then jumped by 102.61% to $2.8 billion in 2023, then fell by 10.53% to $2.5 billion in 2024, then declined by 11.2% to $2.2 billion in 2025, then dropped by 5.95% to $2.1 billion in 2026.
• According to Business Quant data, Inventory Average over the past three periods registered $2.1 billion, $2.2 billion, and $2.2 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.